Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Effects of Inspiratory Muscle Training on Cardiovascular Function in Hypertension. [NA]
A clinical trial investigates whether inspiratory muscle training improves blood pressure and cardiovascular autonomic control in hypertensi…
-
FDA approval · 2010-11-29FDA Approved: TRANDOLAPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the generic drug trandolapril from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function [Phase 4]
Phase 4 trial comparing nebivolol to metoprolol succinate in hypertension to assess effects on endothelial function; study completed.
-
FDA approval · 2010-11-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA's entry shows a supplemental application submission for Cardizem LA (diltiazem hydrochloride extended-release). The sponsor is Bausch He…
-
FDA approval · 2010-11-22FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental NDA for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Self-Management in African Americans With Diabetes and Hypertension [Phase 2]
A Phase 2 clinical trial update evaluating self-management education for African Americans with diabetes and hypertension that has completed…
-
FDA approval · 2010-11-16FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Losartan Potassium 25 mg from Strides Pharma Science Limited, adding a new dosage strength to th…
-
CLINICAL_TRIALS trial_result · 2010-11-11Clinical Trial Update: Combined Antihypertensive Therapy and Sexual Dysfunction [Phase 4]
Phase 4 clinical trial update on combined antihypertensive therapy and sexual dysfunction; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension [Phase 4]
Phase 4 clinical trial updates the efficacy and safety of the valsartan/hydrochlorothiazide combination for hypertension.
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: Perioperative Myocardial Ischemia in Isolated Systolic Hypertension
A completed clinical trial evaluating perioperative myocardial ischemia in patients with isolated systolic hypertension.
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: Metro Atlanta Heart Disease Study - II (MAHDS II) [Phase 1]
Phase 1 MAHDS II trial update shows completion of the study status for African Americans with hypertension, sponsored by Morehouse School of…
-
FDA approval · 2010-11-01FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Hydralazine Hydrochloride (generic) from Teva Pharmaceuticals USA, Inc., authorizing the generic…
-
FDA approval · 2010-11-01FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA has approved a supplemental application for Hydralazine hydrochloride from Teva Pharmaceuticals USA, Inc., supporting an update to a…
-
FDA approval · 2010-11-01FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydralazine hydrochloride (Teva Pharmaceuticals USA, Inc.) under ANDA 089097, updating an alread…
-
CLINICAL_TRIALS research · 2010-10-28Clinical Trial Update: Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria [Phase 3]
A Phase 3 clinical trial comparing the antiproteinuric effects of imidapril versus ramipril in adults with type 2 diabetes and hypertension …
-
FDA approval · 2010-10-26FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for benazepril hydrochloride from Solco Healthcare U.S., LLC, supporting its use as a generic AC…
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy [Phase 3]
Phase 3 clinical trial update evaluating the combination of irbesartan and amlodipine in hypertensive patients who are not adequately contro…
-
CLINICAL_TRIALS research · 2010-10-26Clinical Trial Update: Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy [Phase 3]
Phase 3 trial evaluating irbesartan in combination with amlodipine for hypertension in patients inadequately controlled on amlodipine monoth…
-
FDA approval · 2010-10-25FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Hydralazine Hydrochloride from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2010-10-25FDA Approved: METOPROLOL — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original ANDA for metoprolol tartrate by Fresenius Kabi USA, LLC, a generic beta-blocker. It is indicated for hypertension,…
-
FDA approval · 2010-10-22FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for amlodipine besylate.
-
FDA approval · 2010-10-22FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2010-10-21FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for carvedilol by Dr. Reddy's Laboratories Limited, enabling a new generic carvedilol product.
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure [Phase 1]
Phase 1 trial comparing COREG CR with COREG CR fixed-dose combination in hypertensive patients has completed.
-
FDA approval · 2010-10-18FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.